French international pioneer in respiratory health.

Based in Nice, this excellence center aims to develop innovative approaches for diagnosing, treating and preventing respiratory diseases.

Our Upcoming Events

International congress in Nice exploring the impact of AI in thoracic pathology and its clinical applications in respiratory health.
Events
AI in the Next World of Thoracic Pathology
10/06/2026
- 10/07/2026
L’Intelligence Artificielle au service du diagnostic en pathologie thoracique L’IHU RespirERA organise à Nice (hôtel...

Our News

WHO updates the global lung cancer classification with the contribution of Professor Paul Hofman, Director of IHU RespirERA.
Featured
Lung cancer: WHO brings together global experts to update the reference classification
From 27 to 29 April 2026, a consortium of global lung cancer experts met at the headquarters of IARC...
A look back at Prof. Paul Hofman’s presentation at the Cancer Area seminar on thoracic pathology and lung cancer.
Congress
Thoracic Pathology: Prof. Paul Hofman Shares His Expertise at the Cancer Area Seminar
On April 22, Prof. Paul Hofman took part in a seminar organized by Cancer Area in Barcelona...
A new mechanism of action for glucocorticoids has been discovered in collaboration with IHU RespirERA.
Publication
Glucocorticoids: a hidden discovery in some of the world’s most widely used drugs
Researchers from IRCAN, in collaboration with IHU RespirERA in Nice, have identified a new mechanism of action of glucocorticoids...

Our Strategic Priorities

IHU RespirERA structures its actions around four complementary strategic priorities. Together, they aim to improve the understanding and prevention of respiratory diseases, enhance their diagnosis, personalize patient care, and widely disseminate research-driven innovations for the benefit of patients and society.

Our Missions

IHU RespirERA is committed to five key missions to explore the impact of aging and the environment on respiratory health, placing the patient at the heart of its projects.
Understand

the mechanisms of respiratory diseases to better address them.

Prevent

by identifying environmental risk factors and developing effective prevention strategies.

Treat

by creating personalized treatments tailored to each patient’s specific needs.

Innovate

by integrating new technologies, including artificial intelligence and robotics, to enhance diagnosis and care.

Educate & Train

healthcare professionals and the general public on emerging technologies and best practices.

Our Strategy

IHU RespirERA is built on a synergy between researchers, clinicians, patient associations, and industry partners, fostering effective collaboration to understand and treat respiratory diseases. This holistic approach considers all aspects of these pathologies, from biological factors to environmental impacts, to develop comprehensive and innovative solutions. The Provence-Alpes-Côte d’Azur region, significantly affected by pollution and an aging population, serves as our "living laboratory", enabling us to develop real-world solutions tailored to environmental and health challenges.

Our Projects

Discover our flagship projects that need your support!

Lung Cancer Screening
IHU RespirERA is a leading actor in the deployment of lung cancer screening in France.

Support Us

to give new life to research!

By supporting IHU RespirERA, you are directly contributing to the funding of our innovative projects across all areas of respiratory health.

Every donation is a breath of fresh air for research.

Our Founding Members

Our Institutional Support

Supported by the ANR through France 2030: ANR-23-IAHU-0007